PROM1 and medulloblastoma: Singh and colleagues used the cell surface marker CD133 (prominin-1) to sort out a clonogenic population of cells demonstrating stem-like features in medulloblastomas and pilocytic astrocytomas with capabilities of self-renewal and multilineage differentiation and declared these cells to be brain tumor stem cells [14].